Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001159036-25-000026
Filing Date
2025-05-06
Accepted
2025-05-06 16:08:30
Documents
82
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q halo-20250331.htm   iXBRL 10-Q 1220592
2 EX-10.1 ex1012025deal-nominationpsu.htm EX-10.1 90996
3 EX-10.2 ex1022025relativetsrpsu.htm EX-10.2 91616
4 EX-31.1 ex31110qq12025.htm EX-31.1 12946
5 EX-31.2 ex31210qq12025.htm EX-31.2 12886
6 EX-32 ex3210qq12025.htm EX-32 13881
12 GRAPHIC halo-20250331_g1.jpg GRAPHIC 15840
13 GRAPHIC halo-20250331_g2.jpg GRAPHIC 2396149
14 GRAPHIC halo-20250331_g3.jpg GRAPHIC 610040
  Complete submission text file 0001159036-25-000026.txt   14766689

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20250331.xsd EX-101.SCH 48661
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT halo-20250331_cal.xml EX-101.CAL 79123
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT halo-20250331_def.xml EX-101.DEF 248939
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20250331_lab.xml EX-101.LAB 658778
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20250331_pre.xml EX-101.PRE 451712
85 EXTRACTED XBRL INSTANCE DOCUMENT halo-20250331_htm.xml XML 1138336
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 25917281
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)